Further, PS exposure due to the treatment of cancer cells with the condition media of CpG-2722-activated splenocytes was blocked via neutralizing antibodies against TNF-α, IFN-γ, and Trail or their combination (Figure 8D). Here, IFNG is linked to cancer.